305 related articles for article (PubMed ID: 27370896)
1. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
2. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
3. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
4. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer.
Liu Y; Xi J; Zhou L; Wu H; Yue D; Zhu W; Lin J; Lu J; Zhao C; Qiao K
J Clin Neurosci; 2019 Jul; 65():41-45. PubMed ID: 31072737
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
8. [A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Tsukiji J; Kaneko T; Saito H; Kobayashi M; Kakemizu N; Komatsu S; Nishiyama H; Amano H; Miura K; Satoh T; Shinohara T; Mishima W; Yamakawa Y; Nishihira R; Miyashita A; Noda K; Ishigatsubo Y; Matsuse T
Nihon Kokyuki Gakkai Zasshi; 2004 Sep; 42(9):820-4. PubMed ID: 15500150
[TBL] [Abstract][Full Text] [Related]
9. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
Wang S; Bruzzi J; Rodriguez-Garza VP; Komaki RR
Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
[TBL] [Abstract][Full Text] [Related]
10. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
12. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
13. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
Titulaer MJ; Maddison P; Sont JK; Wirtz PW; Hilton-Jones D; Klooster R; Willcox N; Potman M; Sillevis Smitt PA; Kuks JB; Roep BO; Vincent A; van der Maarel SM; van Dijk JG; Lang B; Verschuuren JJ
J Clin Oncol; 2011 Mar; 29(7):902-8. PubMed ID: 21245427
[TBL] [Abstract][Full Text] [Related]
14. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
Hülsbrink R; Hashemolhosseini S
Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
[TBL] [Abstract][Full Text] [Related]
15. Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambert-Eaton myasthenic syndrome.
Nagashima T; Mizutani Y; Kawahara H; Maguchi S; Terayama Y; Shinohara T; Orba Y; Chuma T; Mano Y; Itoh T; Sawa H; Sakai K; Motomura M; Nagashima K
Neuropathology; 2003 Sep; 23(3):230-8. PubMed ID: 14570293
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
17. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome in patients with small cell lung cancer: Report of five cases.
Hao Y; Hu J; Zhang Y; Liu W; Lu S; Zhang M
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C95-6. PubMed ID: 26323934
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
20. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]